Janoff AS - Search Results

1

Optimizing combination chemotherapy by controlling drug ratios.

Mayer LD, Janoff AS. Mayer LD, et al. Among authors: janoff as. Mol Interv. 2007 Aug;7(4):216-23. doi: 10.1124/mi.7.4.8. Mol Interv. 2007. PMID: 17827442 Review.

2

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.

Mayer LD, Harasym TO, Tardi PG, Harasym NL, Shew CR, Johnstone SA, Ramsay EC, Bally MB, Janoff AS. Mayer LD, et al. Among authors: janoff as. Mol Cancer Ther. 2006 Jul;5(7):1854-63. doi: 10.1158/1535-7163.MCT-06-0118. Mol Cancer Ther. 2006. PMID: 16891472

3

Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors.

Batist G, Gelmon KA, Chi KN, Miller WH Jr, Chia SK, Mayer LD, Swenson CE, Janoff AS, Louie AC. Batist G, et al. Among authors: janoff as. Clin Cancer Res. 2009 Jan 15;15(2):692-700. doi: 10.1158/1078-0432.CCR-08-0515. Clin Cancer Res. 2009. PMID: 19147776 Clinical Trial.

4

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).

Allen C, Dos Santos N, Gallagher R, Chiu GN, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS, Bally MB. Allen C, et al. Among authors: janoff as. Biosci Rep. 2002 Apr;22(2):225-50. doi: 10.1023/a:1020186505848. Biosci Rep. 2002. PMID: 12428902 Review.

5

Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.

Smalling RW, Feld S, Ramanna N, Amirian J, Felli P, Vaughn WK, Swenson C, Janoff A. Smalling RW, et al. Circulation. 1995 Aug 15;92(4):935-43. doi: 10.1161/01.cir.92.4.935. Circulation. 1995. PMID: 7641377

6

Lipids, liposomes, and rational drug design.

Janoff AS. Janoff AS. Lab Invest. 1992 Jun;66(6):655-8. Lab Invest. 1992. PMID: 1602736 No abstract available.

7

Private development companies: transforming academic research into new treatment options for cancer.

Janoff AS. Janoff AS. Mol Interv. 2010 Apr;10(2):65-8. doi: 10.1124/mi.10.2.2. Mol Interv. 2010. PMID: 20368364 Review. No abstract available.

8

Editorial.

Janoff AS. Janoff AS. J Liposome Res. 2005;15(1-2):1-2. doi: 10.1081/lpr-64520. J Liposome Res. 2005. PMID: 16194923 No abstract available.

9

A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections.

Adedoyin A, Swenson CE, Bolcsak LE, Hellmann A, Radowska D, Horwith G, Janoff AS, Branch RA. Adedoyin A, et al. Among authors: janoff as. Antimicrob Agents Chemother. 2000 Oct;44(10):2900-2. doi: 10.1128/AAC.44.10.2900-2902.2000. Antimicrob Agents Chemother. 2000. PMID: 10991885 Free PMC article. Clinical Trial.

10

Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.

Subang R, Levine JS, Janoff AS, Davidson SM, Taraschi TF, Koike T, Minchey SR, Whiteside M, Tannenbaum M, Rauch J. Subang R, et al. Among authors: janoff as. J Autoimmun. 2000 Aug;15(1):21-32. doi: 10.1006/jaut.2000.0382. J Autoimmun. 2000. PMID: 10936025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters